Evidence map›Paper›PMID 24445868›Full record

ArticleLeukemia2014

Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib.

T L Lasho, A Mims, M A Elliott, C Finke, A Pardanani, A Tefferi

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Archives of medical science : AMS · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Current Management of Chronic Neutrophilic Leukemia.Current treatment options in oncology · 2021
    Review
  9. Article
  10. Article
  11. [Ruxolitinib for chronic neutrophilic leukemia: a case report and literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2018
    Article
  12. Article
  13. Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018
    Article
  14. Article
  15. Review
  16. Chronic neutrophilic leukemia.Proceedings (Baylor University. Medical Center) · 2018
    Article
  17. Review
  18. Oncotarget · 2017
    Review
  19. Review
  20. Somatic SETBP1 mutations in myeloid neoplasms.International journal of hematology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

T L LashoDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
A MimsDivision of Hematology and Oncology, Medical University of South Carolina, Charleston, SC, USA.
M A ElliottDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
C FinkeDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
A PardananiDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
A TefferiDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic · USMayo Clinic in Florida · USMayo Clinic in Arizona · USMedical University of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntineoplastic AgentsBreast NeoplasmsCarrier ProteinsCombined Modality TherapyDrug Resistance, NeoplasmErythroid CellsFemaleGranulocytesHumansHydroxyureaIn Vitro TechniquesJanus Kinase 2Leukemia, Neutrophilic, ChronicMutationNitrilesAntineoplastic AgentsCarrier ProteinsCSF3R protein, humanHydroxyureaJAK2 protein, humanJanus Kinase 2NitrilesNuclear ProteinsPyrazolesPyrimidinesReceptors, Colony-Stimulating FactorruxolitinibSETBP1 protein, human

Identifiers

PMID24445868
OpenAlexW1998912715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.